Two recent books, Marcia Bjornerud’s “Turning to Stone” and Tamsin Mather’s “Adventures in Volcanoland,” explore certain mechanisms of our home planet vital to our existence, adding the caveat that ...

LEIDEN, Netherlands, Jan. 8, 2025 /PRNewswire/ -- Alesta Therapeutics, a biotechnology company focused on developing transformative small molecule therapies for rare diseases, today announced the ...

About Leap Therapeutics Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized ...

Investing.com - Edgewise Therapeutics (NASDAQ: EWTX) reported fourth quarter EPS of $-0.47, $0.04 worse than the analyst estimate of $-0.43. Revenue for the quarter came in at... ByInvesting.com • 23 ...

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that the European Medicines Agency (EMA) has granted Orphan Drug... ByInvesting.com • ...

Omega Therapeutics ( (OMGA)) has shared an announcement. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with ...

Edgewise Therapeutics (NASDAQ:EWTX) is building itself up as a good long-term biotech to hang onto. Especially, when you consider that it was able to report positive results from its phase 2 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

ADC Therapeutics (ADCT) announced the completion of enrollment in LOTIS-5, the Phase 3 confirmatory trial evaluating Zynlonta in combination with rituximab in patients with relapsed or refractory ...